Treatment of fibrinous effusion.
Starck
T
T
D002387:Cataract Extraction / Q000009:adverse effects; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D006988:Hyphema / Q000188:drug therapy / Q000209:etiology; D007267:Injections; D010960:Plasminogen Activators / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000188:drug therapy*; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D011994:Recombinant Proteins; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator